Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, October 12, 2022
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
[ Wed, Oct 12th 2022
] - WOPRAI
Tue, October 11, 2022
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
[ Tue, Oct 11th 2022
] - WOPRAI
Drew Ranieri Maintained (TMCI) at Buy with Increased Target to $28 on, Oct 11th, 2022
Drew Ranieri of Morgan Stanley, Maintained "Treace Medical Concepts, Inc." (TMCI) at Buy with Increased Target from $23 to $28 on, Oct 11th, 2022.
Drew has made no other calls on TMCI in the last 4 months.
There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 0 agree with Drew's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Drew
- Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $27 on, Wednesday, September 21st, 2022
- Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Increased Target to $28 on, Wednesday, September 21st, 2022
